Your browser doesn't support javascript.
loading
Rapid production and free distribution of a synthetic RNA material to support SARS-CoV-2 molecular diagnostic testing.
Cleveland, Megan H; Romsos, Erica L; Steffen, Carolyn R; Olson, Nathan D; Servetas, Stephanie L; Valiant, William G; Vallone, Peter M.
Afiliación
  • Cleveland MH; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA. Electronic address: megan.cleveland@nist.gov.
  • Romsos EL; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA.
  • Steffen CR; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA.
  • Olson ND; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA.
  • Servetas SL; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA.
  • Valiant WG; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA.
  • Vallone PM; National Institute of Standards and Technology, 100 Bureau Dr, Gaithersburg, MD, 20899, USA.
Biologicals ; 82: 101680, 2023 May.
Article en En | MEDLINE | ID: mdl-37178559
ABSTRACT
In response to the COVID-19 pandemic, the National Institute of Standards and Technology released a synthetic RNA material for SARS-CoV-2 in June 2020. The goal was to rapidly produce a material to support molecular diagnostic testing applications. This material, referred to as Research Grade Test Material 10169, was shipped free of charge to laboratories across the globe to provide a non-hazardous material for assay development and assay calibration. The material consisted of two unique regions of the SARS-CoV-2 genome approximately 4 kb nucleotides in length. The concentration of each synthetic fragment was measured using RT-dPCR methods and confirmed to be compatible with RT-qPCR methods. In this report, the preparation, stability, and limitations of this material are described.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article
...